|
|
|
 |
 |
|
       |
|
|
|
Management Team  Daniel D. Adams President and Chief Executive Officer danadams*@proteinsciences.com (delete '*' to send e-mail) Daniel Adams became CEO of Protein Sciences in 1995. He has previously founded and managed biopharmaceutical companies that have a combined market value of over $10 billion. He co-founded Biogen (OTC-BGEN) and served as its first President and CEO, founded and was CEO of Advanced Genetic Sciences Inc. ("AGS"), and co-founded Plant Genetic Systems in 1982. Dan holds a BA degree in Chemistry from Cornell University and a JD magna cum laude from New York University School of Law. Drs. Manon M. J. Cox, MBA Chief Operating Officer manon.cox*@proteinsciences.com (delete '*' to send e-mail) Manon Cox joined the company in 1998 as Director, Business Development. She has a strong background in biopharmaceutical development, stemming from experience in research and management at Gist-Brocades, a world leader in microbial fermentation. Prior to joining Protein Sciences, she was Manager, New Business Development, Biopharmaceuticals for Gist-Brocades. Manon holds a Drs degree in Molecular Biology, Genetics and Biochemistry from the University of Nijmegen, The Netherlands and a MBA with distinction from the University of Nijenrode (The Netherlands) and the University of Rochester, NY (USA). Penny L. Post, Ph.D. Director of Quality and Regulatory Affairs penny.post*@proteinsciences.com (delete '*' to send e-mail) Penny Post joined Protein Sciences Corporation in the spring of 2000 as Scientist, Process Development and Project Manager. She has a strong background in biochemistry and protein purification. At Protein Sciences, Penny has been involved in the development of purification methods for recombinant proteins involved in diseases such as influenza and AIDS as well as the manufacturing of HIV vaccines. Penny has served as Director of Manufacturing, Director of Quality Control, and now Director of Quality and Regulatory Affairs at Protein Sciences. Prior to joining Protein Sciences, Penny was a postdoctoral fellow and associate research scientist in the Molecular, Cellular, and Developmental Biology Department at Yale University, where she received her own funding to do her research. Penny holds a B.A. in Biology from Middlebury College and a Ph.D. in Biochemistry and Cell Biology from Carnegie Mellon University. Her thesis work received Paper of the Year in 1996 in Molecular Biology of the Cell. Joseph A. Rininger, Ph.D. Director of Business Development jrininger*@proteinsciences.com (delete '*' to send e-mail) Joe Rininger joined Protein Sciences in January 2004 as Manager of Business Development and was promoted to Director of Business Development in April 2006. Joe holds a Ph.D. in Toxicology, Pharmacology and Immunology from Cornell University and has been working in the biotechnology industry since 1991. He has experience in conducting research, product development, the establishment and management of contractual service development projects. Prior to joining Protein Sciences, he was a Project Leader at CuraGen Corporation in their Pharmacogenomics services group. Advisory Team Thomas Kowalski Legal Advisor TKowalski*@FLHLaw.com (delete '*' to send e-mail) Thomas J. Kowalski is a partner in Frommer Lawrence & Haug LLP (www.FLHLaw.com), a full service U.S. intellectual property law firm, based in NYC, with offices in NYC and San Diego CA, that handles all aspects of intellectual property law, including patent, trademark, and copyright prosecution, counseling, and litigation, and related matters, including regulatory/FDA matters. Thomas graduated from NYU with a B.S. in Chemistry. His studies were those in fulfillment of the requirements for American Chemistry Society certification of the degree, and included Graduate Biochemistry, Graduate Inorganic Chemistry, Genetics, Computer Science and Laboratory Research. He was also awarded a NSF Grant for Laboratory Research; the results of which were published in the Journal of Organic Chemistry. Thomas was awarded the degree of J.D. cum laude from St. John's University. He has been in practice for over 16 years. R. Frank Ecock Strategic Planning and Manufacturing Advisor He is currently Senior Vice President, Strategic Planning, at Mova Pharmaceutical Corporation. Before that, Frank spent 33 years with Merck, retiring in 1991. He ultimately served as Vice President of North American operations where he was responsible for all operations, quality control and engineering support for five plants and 5,000 person headquarters site. His activities supported $6 billion in revenue and he supervised 3,000 persons. Alex P. C. Toles Process & Regulatory Advisor Alex Toles was the company's first employee, joining in 1984. He has served in managerial capacities related to operating the company's pilot manufacturing plant, managing cGMP clinical manufacturing, and directing Regulatory Affairs, Quality Control and Quality Assurance. Alex holds a BS in Environmental Resource Management and Biology from Pennsylvania State University. |
|
|
|
|||||||||||||||||||||||||||
|
|
|
|
|
|
|
